Qube Research & Technologies (QRT)’s Moderna MRNA Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$19.3M	Sell	380,100 -419,800	-52%	-$19.6M	0.02%	899
2025 Q4	$23.6M	Sell	799,900 -80,000	-9%	-$2.17M	0.02%	822
2025 Q3	$22.7M	Sell	879,900 -810,400	-48%	-$22.6M	0.02%	833
2025 Q2	$46.6M	Buy	1,690,300 +525,000	+45%	+$13.8M	0.05%	499
2025 Q1	$33M	Buy	1,165,300 +82,600	+8%	+$2.93M	0.04%	542
2024 Q4	$45M	Buy	1,082,700 +828,400	+326%	+$39.6M	0.06%	412
2024 Q3	$17M	Buy	254,300 +164,900	+184%	+$15.1M	0.03%	760
2024 Q2	$10.6M	Buy	89,400 +60,900	+214%	+$7.71M	0.02%	887
2024 Q1	$3.04M	Sell	28,500 -77,200	-73%	-$7.78M	﹤0.01%	1516
2023 Q4	$10.5M	Sell	105,700 -20,500	-16%	-$1.72M	0.02%	715
2023 Q3	$13M	Buy	+126,200	New	+$14.1M	0.03%	541

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Qube Research & Technologies (QRT)'s MRNA Position: Q1 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Moderna (MRNA) in Q1 2026: 700,692 shares worth $35.6M. The stake represents 0.04% of the portfolio and ranks #566 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in MRNA as recently as Q4 2024.

Qube Research & Technologies (QRT) first reported a position in MRNA in Q1 2020 and has held it in 13 quarters since. The position peaked at $37.7M in Q4 2022. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

Qube Research & Technologies (QRT) held 700,692 shares of Moderna worth $35.6M as of Q1 2026.
Moderna was a new Qube Research & Technologies (QRT) position in Q1 2026.
Moderna made up 0.04% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #566 holding.
Qube Research & Technologies (QRT) first reported a position in Moderna in Q1 2020 and has held it in 13 quarters since.
Qube Research & Technologies (QRT)'s Moderna position peaked at $37.7M in Q4 2022.
722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.